Top Stories News

Education can help to allay patients' concerns over participating in clinical trials

Scientists are a step closer to a universal flu vaccine

A class of pharmaceuticals seem to prevent Alzheimer's disease

US scientists have discovered certain biomarkers for IBD

Phase IIa clinical trial suggests asthma treatment may be effective

Natural ingredients specialised nutrition company Newtricious has appointed its first supervisory board.

The Alzheimer's disease drug is now available in US pharmacies.

A phase three clinical trial of eribulin mesylate suggested it may be the optimal treatment in certain patient populations.

The subsector experienced growth of three per cent between 2010 and 2012.

High levels of the G6P metabolite could disrupt pump function and cause heart failure.

Generic drugs account for more than 70% of prescriptions dispensed in the U.S. and that figure is expected to grow as brand drugs come off patent and face generic competition.

Researchers have developed a new approach to restoring nitric oxide to blood, paving the way for significant developments.

Iroko Pharma has announced that it will withdraw its initial public offering.

A one billion dollar pharmaceutical deal in the Middle East has been jeopardised by anti-government protests in the region.

Approval has been granted for Wockhardt to market generic Lamotrigine tablets in various dosages.

Roche has announced a new process for making its clinical trial data more transparent.

Scientists are confident that they are making progress in the treatment for type 1 diabetes, developing a new vaccine that effectively shuts down the immune system.

The UK Biomedical Catalyst Fund has granted £2.4 million funding for the development of DMD treatment.

XTANDI is a treatment option for prostate cancer patients who are resistant to first-line therapy.

The computer model should facilitate the design of superior AD clinical trials.

Clinical research experts believe that employers should take a more broad-minded approach to recruitment.

Operating to remove the fallopian tubes could cut the risk of ovarian cancer.

Success for health product specialist Cyanotech in the third quarter of fiscal 2013.

The drug prevents tumour growth through inhibition of HSP90.

The unique hTee technology can aid patient management for those undergoing heart surgery.

Oncologists may omit vital chemotherapy doses when supplies are low.

The KKL-35 antibiotic could treat anthrax and tuberculosis by disrupting trans-translation.

Fat has been shown to trigger rheumatoid arthritis

Despite previous clinical trials suggesting that antioxidants can help women conceive, a new review says that this is not enough. Women who undergo fertility treatment are often encouraged to take dietary supplements that contain antioxidants. Yet th...

New data is helping improve immunisation strategies in the treatment of dengue fever.

A common treatment for epilepsy has been launched in the UK in liquid form

Scientists have discovered how to manipulate a mutant protein to kill cancer

A breakthrough on how T cells operate after stem cell transplants could lead to improvements in the process

A figure-8 valvuplasty balloon catheter has received 510(k) clearance in the US

US pharma firm Achaogen has signed a new deal to push forward its research into plazomicin.

A synthetic form of vitamin D could be used to prevent the progression of liver fibrosis.

A study from the US has identified potential methods for detecting colorectal cancer.

A new report from Ernst & Young has named the Midwest as America’s leading region for bioscience research.

A new toll has been launched for live cell imaging.

A new tablet device has been developed for the pharmaceutical industry.

A herpes treatment has been given market authorisation by the US FDA.

A phase 2 study has shown promise for a new treatment aimed at sickle cell disease patients.

Tolvaptan is being reviewed as a potential treatment for ADPKD.

A natural soy-based compound could be used for the treatment of colorectal cancer.

A new molecule is being developed as a therapeutic for prostate cancer.

An alternative treatment to statins could be on the horizon.

New website to help potential trial participants locate their closest trial.

Icon has acquired Cross County Healthcare's Clinical Trial Services Division.

Revolutionary kidney augment trial gets green light.

New research suggests curcumin can help prevent arterial stiffness, a major risk factor for heart disease in postmenopausal women.

RedHill BioPharma of Israel is to start work on testing its new migraine treatment in the US.

England's Oxford Pharmascience has secured fresh funding for its research and development efforts.

The industry helps to support the economy in Texas.

Antibody development company announces project funding.

EU to get new drug for treating HIV-1 infection.

Officials in the US have given their approval to the patent.

Meir Pugatch explained that Europe has a low level of clinical trials activity.

IT is helping scientists to spend more money on actual lab work.

AstraZeneca will invest in several of its existing research and development centres around the world.

A new drug to treat HER2-positive breast cancer has received regulatory approval in the UK.

The pharmaceutical industry could benefit by developing new drug formulations that are cheaper than existing remedies.

The UK government intends to take steps to attract drug research and development projects back to the UK.

The Stentys Self-Apposing Stent clinical trials show low death rates in patients following severe heart attack.

The executive vice president chief operating officer of the company, which specialises in drug formulations for unmet medical needs, is leaving for other opportunities.

Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting.

OMP-52M51 is a therapeutic that targets cancer stem cells.

Tests involving the delivery of an immune system-enhancing drug to patients suffering from colorectal cancer have shown promise.

A new independent company called AbbVie has been formed to take forward Abbott's research-based pharmaceuticals business.

Saudi Arabia is one of the largest pharmaceutical markets in the Middle East and is due to experience steady growth.

Dr Joerg Reinhardt will be the new chairman of Novartis, succeeding Dr Daniel Vasella.

OvaSciences enjoyed a strong year with most of its R&D spend coming on CROs for a major new trial.

Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights.

The Digital Pharma Experience takes place in Prague in May.

Diagnovus' new gene expression assay aims to provide more accurate risk profiles for DLBCL patients.

Roche has acquired global licencing rights for the acromegaly treatment, which is in phase three trials.

The two firms are collaborating to improve their green performance and enzyme process development.

Neurotrophic keratitis patients to get eyedrop treatment.

New treatment to help mild sufferers of ulcerative colitis.

Cancer research organisation will include six new members.

BioMed has launched its new pharmacy management system RxVector.

New diagnostic tests to be developed as a result of funding.

Affymetrix and DNA Link team up to consumerise DNA identification technology .

Genentech has seen positive results in Phase III trials of its CLL drug.

Vertex will continue with its research into cystic fibrosis, hepatitis C and autoimmune diseases this year.

New innovations in the medical adhesives sector will accelerate the move away from the use of sutures and staples.

Japan recognises birinapant innovation.

Asia to get new visualisation technology from Sectra.

BioSante and ANI Pharmaceuticals arrange special meetings for merger.

US foundation commits £25 million to fighting pancreatic cancer.

Avoca's outsourcing group has set out its key goals for 2013.

Patients will no longer have to undergo painful autografting for second-degree burns.

BioChemics ventures into wound treating market.

Independent pharmaceutical companies to discuss the changing industry.

Scientific medal goes to Dr Lucy Shapiro of Anacor Pharmaceuticals.

Spectrum announces new arrival plus its plan for the next five years.

Device outsourcing set to rise exponentially between now and 2018.

Number of pharmaceutical companies using outsourcing increases.

A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020.

Funding for research and treatment of brain tumours is 'lagging behind' other cancers, says a charity.

Repligen Corp. has entered into an exclusive worldwide licensing agreement with Pfizer to advance its spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).

Tranzyme Pharma has successfully completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb and has transferred compounds, across multiple drug targets, to BMS for further development.

GlobalData's latest report looks at the prospects for the pharmaceutical industry in Israel.

A new report looks at the potential for growth in the Chinese pharmaceutical market.

GSK has formed a partnership with Vodafone to harness innovative mobile technology to help vaccinate more children against common infectious diseases in Africa.

Decision Resources has published its latest predictions for the epilepsy drug market through 2021.

GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation

A new report suggests that more and more pharmaceutical companies are devoting dedicated budgets to health economics and outcomes research.

Ranbaxy, Inc., a subsidiary of India’s Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium tablets (10 mg, 20 mg and 40 mg), a generic of Pfizer’s Lipitor.

German company Schott has announced plans to increase its production capacity in Russia by more than 50 per cent.

Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim

GSK has offered to increase its stake in GSK Consumer Healthcare in India.

The NEOMED Institute is a new public-private partnership between biopharmaceutical companies and the Quebec government.

A growing number of biopharmaceutical products have cold chain requirements, according to IMARC Group's latest report.

A new report by PwC has highlighted the challenges faced by pharmaceutical companies if they are to succeed beyond 2020.

TechNavio's latest report looks at the potential for growth in the diabetes drugs market.

The Department of Biotechnology (DBT) is planning to set up two advanced institutes for research including an Institute of Chronic Disease and Biotechnology.

The Medicines and Healthcare Products Agency (MHRA) is having consultations with the pharma industry and clinical research organisations (CROs) about the European Commission’s proposal to have a new clinical trials regulation.

Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman.